1. Human antibodies against Mycobacterium avium ssp. paratuberculosis combined with cytokine levels for the diagnosis and selection of Crohn's disease patients for anti-mycobacterial therapy-A pilot study.
- Author
-
Kuenstner JT, Zhang P, Potula R, Galarneau JM, and Bach H
- Subjects
- Humans, Male, Female, Pilot Projects, Adult, Middle Aged, Antibodies, Bacterial blood, Antibodies, Bacterial immunology, Case-Control Studies, Paratuberculosis immunology, Paratuberculosis microbiology, Paratuberculosis blood, Paratuberculosis diagnosis, Antigens, Bacterial immunology, Young Adult, Prospective Studies, Anti-Bacterial Agents therapeutic use, Crohn Disease immunology, Crohn Disease drug therapy, Crohn Disease blood, Crohn Disease microbiology, Mycobacterium avium subsp. paratuberculosis immunology, Cytokines blood
- Abstract
Increasing evidence links a worldwide bacterial infection of cattle and other animal species by Mycobacterium avium ssp. paratuberculosis (MAP) to Crohn's disease (CD). A large, FDA phase 2/3 controlled clinical trial of combination antimycobacterial antibiotic therapy for CD has been completed, and the report describing the trial is pending publication. The identification of MAP infection in CD patients will become increasingly important. Thus, it is desirable to develop MAP-based tests that accurately predict which CD patients have a MAP infection. A prospective, case-control laboratory test study of 199 subjects (61 CD patients and 138 non-CD controls) was performed using a panel of MAP antigens, including Hsp65, PknG, PtpA, CL1, and MAP IDEXX, which were measured under blind conditions in the plasma of the 199 subjects. Results showed that compared to any individual MAP antigen, combinations of antigens showed improved CD classification performance. For the Hsp65 antigen, the sensitivity (SEN), specificity (SPE), positive predictive value (PPV), negative predictive value (NPV), correct classification (CC), and area under the curve (AUC) were 59.02%, 58.70%, 38.71%, 76.42%, 59.3% and 0.606, respectively. For the best combination of MAP antibodies (Hsp65 and PknG), the SEN, SPE, PPV, NPV, CC, and AUC were 59.02%, 60.87%, 40.00%, 77.06%, 60.30%, and 0.631, respectively. Further improvement of the CD classification performance was achieved by combining IFN-γ, IL-8, and IL-17 cytokines with antibodies against MAP antigens, yielding SEN, SPE, PPV, NPV, CC, and AUC of 62.3%, 62.32%, 42.22%, 78.9%, 62.31% and 0.708, respectively. Thus, combinations of antibodies against MAP antigens and cytokine levels yield better CD diagnostic predictive performance than any individual antibodies against MAP antigens., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: JTK, JMG, HB, PZ, and RP have ownership in US and international patents which have been filed with claims based on the findings of this study., (Copyright: © 2024 Kuenstner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF